World ADC San Diego 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Gilead Sciences at World ADC San Diego 2026

Oct 12–15, 2026 San Diego, CA ~1.3k attendees Website

Gilead Sciences takes part in 3 sessions at World ADC San Diego 2026 in San Diego. Its sessions cover clinical combinations and early clinical results for ADCs, plus quality control for non-cytotoxic conjugates. Topics include pairing TROP2-targeted ADCs with immunotherapy and early clinical data for TUB-040 in platinum-resistant ovarian cancer.

OrganizationWorld ADC San Diego 2026 Attendance
Gilead Sciences
Foster City, CA
gilead.com
Large pharma
Biopharmaceutical company with marketed HIV, liver disease and cancer medicines, including the TROP2 ADC sacituzumab govitecan.
Talk
Tue Oct 13
6:15pm
TROP2 ADC–Immunotherapy Combinations: Clinical Evidence, Emerging Strategies & Future Opportunities
Plenary
Clinical development
Talk
Wed Oct 14
5:00pm
Workshop
Thu Oct 15
1:00pm
Beyond Traditional ADCs: Breaking Down Control Strategies for Non‑Cytotoxic Bioconjugate Modalities
Post-conference workshop for Process & Analytical Development · with Regeneron, Bristol Myers Squibb

Explore the full World ADC San Diego 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full World ADC San Diego 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Gilead Sciences

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by World ADC or its organizers. Submit a correction